The present invention relates to novel antagonists for CCR2 (CC chemokine receptor 2) of formula (Ia) and their use for providing medicaments for treating conditions and diseases, especially pulmonary diseases like asthma and COPD.
-
Page/Page column 86
(2011/12/14)
More Articles about upstream products of 1351865-00-3